News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
AstraZeneca PLC Settles U.S. Pricing Lawsuit for $103 Million
June 21, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Reuters -- AstraZeneca PLC (AZN.L) has agreed to pay $103 million to settle U.S. litigation involving claims the drugmaker inflated prices for its Zoladex cancer drug and Pulmicort Respules asthma medicine.
Twitter
LinkedIn
Facebook
Email
Print
Legal
AstraZeneca Pharmaceuticals LP
MORE ON THIS TOPIC
COVID-19
CDC Names Vaccine Critic Retsef Levi as Head of COVID-19 Workgroup
August 26, 2025
·
2 min read
·
Tristan Manalac
Vaccines
Trump, Kennedy Could Ban COVID-19 Vaccine ‘Within Months’: Report
August 26, 2025
·
2 min read
·
Tristan Manalac
Government
HHS Will No Longer Recognize Employee Unions
August 25, 2025
·
2 min read
·
Tristan Manalac
Tariffs
Trump Administration Settles on 15% Generic Drug Tariff Rate for EU
August 22, 2025
·
1 min read
·
Annalee Armstrong
